{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:33:04Z","timestamp":1792204384800,"version":"4.4.0"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T00:00:00Z","timestamp":1426809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0119755","type":"journal-article","created":{"date-parts":[[2015,3,20]],"date-time":"2015-03-20T15:26:59Z","timestamp":1426865219000},"page":"e0119755","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":105,"title":["Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology"],"prefix":"10.1371","volume":"10","author":[{"given":"Theodoros","family":"Agorastos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon","family":"Chatzistamatiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taxiarchis","family":"Katsamagkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Koliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Daponte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theocharis","family":"Constantinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros C.","family":"Constantinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the HERMES study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","article-title":"Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics","volume":"318","author":"M Quinn","year":"1999","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e9584","DOI":"10.1371\/journal.pone.0009584","article-title":"Declining death rates reflect progress against cancer","volume":"5","author":"A Jemal","year":"2010","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.1989.03420050087046","article-title":"The Papanicolaou test for cervical cancer detection. A triumph and a tragedy","volume":"261","author":"LG Koss","year":"1989","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910520202","article-title":"Second International Workshop on the Epidemiology of Cervical Cancer and Human Papillomaviruses","volume":"52","author":"FX Bosch","year":"1992","journal-title":"Int J Cancer"},{"key":"ref5","first-page":"1","article-title":"Human papillomaviruses and their possible role in squamous cell carcinomas","volume":"78","author":"H zur Hausen","year":"1977","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"JM Walboomers","year":"1999","journal-title":"The Journal of pathology"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer\u2014burden and assessment of causality. J Natl Cancer Inst. 2003;Monogr: 3\u201313.","DOI":"10.1093\/oxfordjournals.jncimonographs.a003479"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014Part B: biological agents","volume":"10","author":"V Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"NW Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology: Results From the ATHENA HPV Study","volume":"135","author":"MH Stoler","year":"2011","journal-title":"American Journal of Clinical Pathology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"PE Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1309\/AJCPTUS5EXAS6DKZ","article-title":"Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results","volume":"136","author":"TC Wright Jr","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"ref13","first-page":"46 e41","article-title":"The ATHENA human papillomavirus study: design, methods, and baseline results","volume":"206","author":"TC Wright Jr","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GCO.0b013e32835c5d10","article-title":"Primary human papillomavirus testing in organized cervical screening","volume":"25","author":"J Dillner","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"G Ronco","year":"2014","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","article-title":"Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia","volume":"96","author":"M Arbyn","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ygyno.2004.11.042","article-title":"Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience","volume":"96","author":"T Agorastos","year":"2005","journal-title":"Gynecologic oncology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"MH Mayrand","year":"2007","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"M Leinonen","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"J Cuzick","year":"2006","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"R Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/ijc.23339","article-title":"Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study","volume":"122","author":"J Cuzick","year":"2008","journal-title":"Int J Cancer"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"g130","DOI":"10.1136\/bmj.g130","article-title":"Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial","volume":"348","author":"KM Elfstrom","year":"2014","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"MJ Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"S de Sanjose","year":"2010","journal-title":"The lancet oncology"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/JCM.02116-14","article-title":"A Study of Genotyping for the Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results","volume":"53","author":"M Schiffman","year":"2015","journal-title":"J Clin Microbiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e8667","DOI":"10.1371\/journal.pone.0008667","article-title":"Common genetic variants and risk for HPV persistence and progression to cervical cancer","volume":"5","author":"SS Wang","year":"2010","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.28666","article-title":"Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort","volume":"135","author":"E Roura","year":"2014","journal-title":"Int J Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ijc.22677","article-title":"Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months","volume":"121","author":"S Bulk","year":"2007","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","article-title":"A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study","volume":"20","author":"M Schiffman","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ygyno.2006.08.053","article-title":"Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies","volume":"104","author":"G Koliopoulos","year":"2007","journal-title":"Gynecol Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology","volume":"287","author":"D Solomon","year":"2002","journal-title":"JAMA"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4137\/CIN.S963","article-title":"Semantic integration of cervical cancer data repositories to facilitate multicenter association studies: the ASSIST approach","volume":"8","author":"T Agorastos","year":"2009","journal-title":"Cancer Inform"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/AOG.0b013e318254f90c","article-title":"2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy","volume":"120","author":"J Bornstein","year":"2012","journal-title":"Obstet Gynecol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(09)70156-1","article-title":"HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial","volume":"10","author":"HC Kitchener","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00038-008-7068-3","article-title":"When to use the odds ratio or the relative risk?","volume":"53","author":"CO Schmidt","year":"2008","journal-title":"Int J Public Health"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1553-2712.2010.00773.x","article-title":"Risk ratios and odds ratios for common events in cross-sectional and cohort studies","volume":"17","author":"ST Wilber","year":"2010","journal-title":"Acad Emerg Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"138","author":"PM Bossuyt","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/jnci\/94.2.102","article-title":"Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesion Triage Study G Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance\/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS)","volume":"94","author":"ME Sherman","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"SD Datta","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref41","first-page":"121","article-title":"Cancer of the Uterus: The Vaginal Smear in Its Diagnosis","volume":"59","author":"HF Traut","year":"1943","journal-title":"Cal West Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(04)16674-9","article-title":"The cervical cancer epidemic that screening has prevented in the UK","volume":"364","author":"J Peto","year":"2004","journal-title":"Lancet"},{"issue":"26","key":"ref43","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"10","author":"J Cuzick","year":"2008","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"M Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"M Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"D Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"P Naucler","year":"2007","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"G Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"Suppl 5","key":"ref49","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"M Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"DC Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"issue":"8","key":"ref51","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"JC Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arcmed.2009.06.003","article-title":"The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change","volume":"40","author":"EL Franco","year":"2009","journal-title":"Arch Med Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/bjc.2013.22","article-title":"Comparing the performance of six human papillomavirus tests in a screening population","volume":"108","author":"J Cuzick","year":"2013","journal-title":"British journal of cancer"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1128\/JCM.05552-11","article-title":"Clinical validation of the cobas 4800 HPV test for cervical screening purposes","volume":"49","author":"DA Heideman","year":"2011","journal-title":"J Clin Microbiol"},{"key":"ref55","first-page":"184 e181","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"JT Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"CJ Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"HA Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/LGT.0b013e3181585870","article-title":"2006 consensus guidelines for the management of women with abnormal cervical screening tests","volume":"11","author":"TC Wright Jr","year":"2007","journal-title":"J Low Genit Tract Dis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ygyno.2010.12.361","article-title":"Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice","volume":"121","author":"W Kinney","year":"2011","journal-title":"Gynecol Oncol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18230","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds","volume":"18","author":"HC Kitchener","year":"2014","journal-title":"Health Technol Assess"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","article-title":"Human papillomavirus and cancer: the epidemiological evidence","volume":"19","author":"N Munoz","year":"2000","journal-title":"J Clin Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"N Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/CEJ.0b013e32832abd5e","article-title":"Prevalence and distribution of high-risk human papillomavirus in Greece","volume":"18","author":"T Agorastos","year":"2009","journal-title":"Eur J Cancer Prev"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/CEJ.0000000000000060","article-title":"Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study","volume":"23","author":"T Agorastos","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"S de Sanjose","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1086\/657321","article-title":"Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings","volume":"202","author":"L Bruni","year":"2010","journal-title":"J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0119755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T01:52:38Z","timestamp":1566438758000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0119755"}},"subtitle":[],"editor":[{"given":"Xuefeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,20]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0119755","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,20]]}}}